{
 "PrintNo":"A672","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-01-09T10:51:57.940331Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-01-09","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"}],
 "Title":"Requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose",
 "Summary":"Requires that for the first opioid analgesic prescription of a calendar year, the prescribing physician shall counsel the patient on the risks of overdose, and inform the patient of the availability of an opioid antagonist, including, but not limited to, naloxone.",
 "LawSection":"Public Health Law","LawCode":"Add ยง3309-b, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to opioid analgesic prescriptions",
 "SameAsPrintNo":"S4096-2019","PreviousVersions":["A7812-2015","A327-2017"]
}